Ning Wang
Impact in
- Cancer Research top 0.1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Pharmacology top 0.05%
- Berberine and alkaloids research
Papers in
-
- RNA modifications and cancer 50
- Circular RNAs in diseases 45
- Epigenetics and DNA Methylation 41
- RNA Research and Splicing 28
- Cancer Research 167
- Cancer-related molecular mechanisms research 80
- MicroRNA in disease regulation 72
- Co-authors
- Yibin Feng (150 shared papers)Hor‐Yue Tan (71 shared papers)Sha Li (40 shared papers)Cheng Zhang (52 shared papers)Ming Hong (18 shared papers)Lixing Lao (6 shared papers)Zhang-Jin Zhang (1 shared paper)Sai‐Wah Tsao (11 shared papers)
- Journals
- PLoS ONE (28 papers)Frontiers in Pharmacology (20 papers)International Journal of Biological Macromolecules (19 papers)International Journal of Molecular Sciences (15 papers)Frontiers in Immunology (14 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Ning Wang
1.2k papers receiving 35.5k citations
Ning Wang's Hit Papers
Peers
Comparison fields: 5 of 228
- Cancer Research 5.2k
- Pharmacology 2.1k
- Virology 1.1k
- Molecular Biology 13.8k
- Immunology 3.4k
Countries citing papers authored by Ning Wang
This map shows the geographic impact of Ning Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Wang more than expected).
Fields of papers citing papers by Ning Wang
This network shows the impact of papers produced by Ning Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Wang. The network helps show where Ning Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.2k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Role of Oxidative Stress and Antioxidants in Liver Diseases Hit paper breakdown → | 2015 | 1415 |
| 2 | Genotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection Hit paper breakdown → | 1993 | 1014 |
| 3 | The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases Hit paper breakdown → | 2016 | 519 |
| 4 | 2009 | 454 | |
| 5 | STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4 Hit paper breakdown → | 2017 | 437 |
| 6 | Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations Hit paper breakdown → | 2009 | 431 |
| 7 | Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy Hit paper breakdown → | 2020 | 343 |
| 8 | Function of Akkermansia muciniphila in Obesity: Interactions With Lipid Metabolism, Immune Response and Gut Systems Hit paper breakdown → | 2020 | 333 |
| 9 | The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases Hit paper breakdown → | 2020 | 322 |
| 10 | Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases Hit paper breakdown → | 2016 | 309 |
| 11 | 2020 | 293 | |
| 12 | 2009 | 291 | |
| 13 | Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management Hit paper breakdown → | 2021 | 262 |
| 14 | 2010 | 244 | |
| 15 | 2017 | 232 | |
| 16 | 1994 | 223 | |
| 17 | 2007 | 219 | |
| 18 | 2012 | 208 | |
| 19 | 2016 | 207 | |
| 20 | 2004 | 190 |
About Ning Wang
Ning Wang is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Oncology and Immunology, having authored 1.2k papers that have together received 36.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (80 papers), MicroRNA in disease regulation (72 papers), RNA modifications and cancer (50 papers), Circular RNAs in diseases (45 papers), Epigenetics and DNA Methylation (41 papers), Autophagy in Disease and Therapy (36 papers), Pharmacological Effects of Natural Compounds (31 papers) and RNA Research and Splicing (28 papers). The work is most often cited by research in Cancer Research (5.2k citations), Pharmacology (2.1k citations), Virology (1.1k citations), Molecular Biology (13.8k citations) and Immunology (3.4k citations). Ning Wang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yibin Feng, Hor‐Yue Tan, Sha Li, Cheng Zhang, Ming Hong, Lixing Lao, Zhang-Jin Zhang, Sai‐Wah Tsao, Xuanbin Wang and Tuofu Zhu. Their work appears in journals such as PLoS ONE, Frontiers in Pharmacology, International Journal of Biological Macromolecules, International Journal of Molecular Sciences and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.